Wikipedia

Tachykinin receptor

Tachykinin receptor
Identifiers
Symbol?
InterProIPR001681
tachykinin receptor 1
Identifiers
SymbolTACR1
Alt. symbolsTAC1R
NCBI gene6869
HGNC11526
OMIM162323
RefSeqNM_001058
UniProtP25103
Other data
LocusChr. 2 p13.1-p12
tachykinin receptor 2
Identifiers
SymbolTACR2
Alt. symbolsTAC2R, NKNAR
NCBI gene6865
HGNC11527
OMIM162321
RefSeqNM_001057
UniProtP21452
Other data
LocusChr. 10 q11-q21
tachykinin receptor 3
Identifiers
SymbolTACR3
NCBI gene6870
HGNC11528
OMIM162332
RefSeqNM_001059
UniProtP29371
Other data
LocusChr. 4 q25

There are three known mammalian tachykinin receptors termed NK1, NK2 and NK3. All are members of the 7 transmembrane G-protein coupled receptor family and induce the activation of phospholipase C, producing inositol triphosphate (so called Gq-coupled).

Inhibitors of NK-1, known as NK-1 receptor antagonists, can be used as antiemetic agents, such as the drug aprepitant.[1]

Binding

The genes and receptor ligands are as follows:[2]

Receptor Gene Preferred ligand
NK1 TACR1 substance P
NK2 TACR2 neurokinin A
NK3 TACR3 neurokinin B

(Hökfelt et al., 2001; Page, 2004; Pennefather et al., 2004; Maggi, 2000)

See also

References

  1. ^ "Aprepitant". NICE. Retrieved 2020-05-10.
  2. ^ Maggi CA (September 1995). "The mammalian tachykinin receptors". General Pharmacology. 26 (5): 911–44. doi:10.1016/0306-3623(94)00292-U. PMID 7557266.

External links

This article is copied from an article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of GNU Free Documentation License.

Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.